A Single-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3023703 in Healthy Subjects
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Evansville |
| State: |
|
Indiana |
| Zip Code: |
|
|
| Conditions: |
|
Healthy Volunteers |
| Purpose: |
|
This is a phase I study of LY3023703 in healthy participants. The purposes of this study are
to look at safety, how well the study drug is tolerated, how much of the study drug gets
into the blood stream, and how long it takes the body to get rid of it when given to humans.
Information about any side effects that may occur will also be collected. Participants will
remain in the study for approximately 3 months. This study is for research purposes only and
is not intended to treat any medical condition.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Overtly healthy individuals based on the history and physical examinations as
determined by the investigator
- Body mass index between 18.5 and 32.0 kilograms per square meter (kg/m^2), inclusive
Exclusion Criteria:
- Have known allergies to LY3023703 or any components of the formulation, celecoxib, or
sulfonamides. Participants with known aspirin allergy, allergic reaction to
nonsteroidal anti-inflammatory drugs (NSAIDs), or allergies or intolerance to other
selective microsomal prostaglandin E synthase (mPGES-1) inhibitors should also be
excluded
- Have the presence of active peptic ulcer disease, gastrointestinal (GI) bleeding,
chronic gastritis, inflammatory bowel disease, or chronic diarrhea, or positive
Helicobacter pylori serology
- Use NSAIDs, celecoxib, aspirin, or acetaminophen (at doses greater than 1 gram per
day) within 14 days of screening
|
| NCT ID: |
|
NCT01632579 |
| Primary Contact: |
|
Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri, 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Evansville, Indiana
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 18, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|